The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
respivert | 571 |
topivert pharma | 144 |
respivert limited and topivert pha… 🛈 | 1 |
respivert limited [ | 1 |
respivert | 4 |
respivert | 49 |
topivert pharma | 13 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
compounds | 85 | 2009 |
novel pharmaceutical formulations | 73 | 2012 |
p38 map kinase inhibitors | 68 | 2008 |
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 map kinase … 🛈 | 52 | 2011 |
aromatic heterocyclic compounds as antiinflammatory compounds | 39 | 2014 |
kinase inhibitor | 37 | 2013 |
2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1 -yl)methyl)-3-(2-… 🛈 | 36 | 2013 |
p38 map kinase inhibitors | 30 | 2008 |
diaryl urea derivatives as p38 kinase inhibitors | 29 | 2014 |
p38map kinase inhibitor | 23 | 2009 |